1 Market Overview
1.1 IVIg Powder Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global IVIg Powder Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 2.5g
1.2.3 1.25g
1.3 Market Analysis by Application
1.3.1 Overview: Global IVIg Powder Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global IVIg Powder Market Size & Forecast
1.4.1 Global IVIg Powder Sales in Value (2017 & 2021 & 2028)
1.4.2 Global IVIg Powder Sales in Volume (2017-2028)
1.4.3 Global IVIg Powder Price (2017-2028)
1.5 Global IVIg Powder Production Capacity Analysis
1.5.1 Global IVIg Powder Total Production Capacity (2017-2028)
1.5.2 Global IVIg Powder Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 IVIg Powder Market Drivers
1.6.2 IVIg Powder Market Restraints
1.6.3 IVIg Powder Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda IVIg Powder Product and Services
2.1.4 Takeda IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols IVIg Powder Product and Services
2.2.4 Grifols IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL IVIg Powder Product and Services
2.3.4 CSL IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma IVIg Powder Product and Services
2.4.4 Octapharma IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Biotest
2.5.1 Biotest Details
2.5.2 Biotest Major Business
2.5.3 Biotest IVIg Powder Product and Services
2.5.4 Biotest IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion IVIg Powder Product and Services
2.6.4 Kedrion IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hualan Bio
2.7.1 Hualan Bio Details
2.7.2 Hualan Bio Major Business
2.7.3 Hualan Bio IVIg Powder Product and Services
2.7.4 Hualan Bio IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business
2.8.3 CNBG IVIg Powder Product and Services
2.8.4 CNBG IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Shanghai RAAS
2.9.1 Shanghai RAAS Details
2.9.2 Shanghai RAAS Major Business
2.9.3 Shanghai RAAS IVIg Powder Product and Services
2.9.4 Shanghai RAAS IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO IVIg Powder Product and Services
2.10.4 CBPO IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 LFB Group
2.11.1 LFB Group Details
2.11.2 LFB Group Major Business
2.11.3 LFB Group IVIg Powder Product and Services
2.11.4 LFB Group IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 BPL
2.12.1 BPL Details
2.12.2 BPL Major Business
2.12.3 BPL IVIg Powder Product and Services
2.12.4 BPL IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Sichuan Yuanda Shuyang
2.13.1 Sichuan Yuanda Shuyang Details
2.13.2 Sichuan Yuanda Shuyang Major Business
2.13.3 Sichuan Yuanda Shuyang IVIg Powder Product and Services
2.13.4 Sichuan Yuanda Shuyang IVIg Powder Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 IVIg Powder Breakdown Data by Manufacturer
3.1 Global IVIg Powder Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global IVIg Powder Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in IVIg Powder
3.4 Market Concentration Rate
3.4.1 Top 3 IVIg Powder Manufacturer Market Share in 2021
3.4.2 Top 6 IVIg Powder Manufacturer Market Share in 2021
3.5 Global IVIg Powder Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and IVIg Powder Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global IVIg Powder Market Size by Region
4.1.1 Global IVIg Powder Sales in Volume by Region (2017-2028)
4.1.2 Global IVIg Powder Revenue by Region (2017-2028)
4.2 North America IVIg Powder Revenue (2017-2028)
4.3 Europe IVIg Powder Revenue (2017-2028)
4.4 Asia-Pacific IVIg Powder Revenue (2017-2028)
4.5 South America IVIg Powder Revenue (2017-2028)
4.6 Middle East and Africa IVIg Powder Revenue (2017-2028)
5 Market Segment by Type
5.1 Global IVIg Powder Sales in Volume by Type (2017-2028)
5.2 Global IVIg Powder Revenue by Type (2017-2028)
5.3 Global IVIg Powder Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global IVIg Powder Sales in Volume by Application (2017-2028)
6.2 Global IVIg Powder Revenue by Application (2017-2028)
6.3 Global IVIg Powder Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America IVIg Powder Sales by Type (2017-2028)
7.2 North America IVIg Powder Sales by Application (2017-2028)
7.3 North America IVIg Powder Market Size by Country
7.3.1 North America IVIg Powder Sales in Volume by Country (2017-2028)
7.3.2 North America IVIg Powder Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe IVIg Powder Sales by Type (2017-2028)
8.2 Europe IVIg Powder Sales by Application (2017-2028)
8.3 Europe IVIg Powder Market Size by Country
8.3.1 Europe IVIg Powder Sales in Volume by Country (2017-2028)
8.3.2 Europe IVIg Powder Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific IVIg Powder Sales by Type (2017-2028)
9.2 Asia-Pacific IVIg Powder Sales by Application (2017-2028)
9.3 Asia-Pacific IVIg Powder Market Size by Region
9.3.1 Asia-Pacific IVIg Powder Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific IVIg Powder Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America IVIg Powder Sales by Type (2017-2028)
10.2 South America IVIg Powder Sales by Application (2017-2028)
10.3 South America IVIg Powder Market Size by Country
10.3.1 South America IVIg Powder Sales in Volume by Country (2017-2028)
10.3.2 South America IVIg Powder Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa IVIg Powder Sales by Type (2017-2028)
11.2 Middle East & Africa IVIg Powder Sales by Application (2017-2028)
11.3 Middle East & Africa IVIg Powder Market Size by Country
11.3.1 Middle East & Africa IVIg Powder Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa IVIg Powder Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of IVIg Powder and Key Manufacturers
12.2 Manufacturing Costs Percentage of IVIg Powder
12.3 IVIg Powder Production Process
12.4 IVIg Powder Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 IVIg Powder Typical Distributors
13.3 IVIg Powder Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
世界の粉末状IVIg市場2022年：市場規模予測（～2028年） |
| 【英語タイトル】Global IVIg Powder Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 | |
 | ・商品コード：GIR22DC3840 ・発行会社（調査会社）：GlobalInfoResearch ・発行日：2023年1月 ・ページ数：108 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（注文後2-3日） ・調査対象地域：グローバル ・産業分野：医薬品 |
| Single User（1名様閲覧用） | USD3,480 ⇒換算￥528,960 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,220 ⇒換算￥793,440 | 見積依頼/購入/質問フォーム |
| Corporate User（同一法人内共有可） | USD6,960 ⇒換算￥1,057,920 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 粉末状IVIg市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の粉末状IVIgの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 粉末状IVIg市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・2.5g、1.25g 用途別セグメントは次のように区分されます。 ・免疫不全、自己免疫疾患、急性感染症 世界の粉末状IVIg市場の主要な市場プレーヤーは以下のとおりです。 ・Takeda、Grifols、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Sichuan Yuanda Shuyang 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、粉末状IVIg製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な粉末状IVIgメーカーの企業概要、2019年～2022年までの粉末状IVIgの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な粉末状IVIgメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別粉末状IVIgの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの粉末状IVIgの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での粉末状IVIg市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および粉末状IVIgの産業チェーンを掲載しています。 ・第13、14、15章では、粉末状IVIgの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 粉末状IVIgの概要 - 種類別分析（2017年vs2021年vs2028年）：2.5g、1.25g - 用途別分析（2017年vs2021年vs2028年）：免疫不全、自己免疫疾患、急性感染症 - 世界の粉末状IVIg市場規模・予測 - 世界の粉末状IVIg生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Takeda、Grifols、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Sichuan Yuanda Shuyang ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：2.5g、1.25g ・用途別分析2017年-2028年：免疫不全、自己免疫疾患、急性感染症 ・粉末状IVIgの北米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・粉末状IVIgのヨーロッパ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・粉末状IVIgのアジア市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・粉末状IVIgの南米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・粉末状IVIgの中東・アフリカ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The IVIg Powder market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global IVIg Powder market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immunodeficiency accounting for % of the IVIg Powder global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 2.5g segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of IVIg Powder include Takeda, Grifols, CSL, Octapharma, and Biotest, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
IVIg Powder market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
2.5g
1.25g
Market segment by Application can be divided into
Immunodeficiency
Autoimmune Disease
Acute Infection
The key market players for global IVIg Powder market are listed below:
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe IVIg Powder product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of IVIg Powder, with price, sales, revenue and global market share of IVIg Powder from 2019 to 2022.
Chapter 3, the IVIg Powder competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IVIg Powder breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and IVIg Powder market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of IVIg Powder.
Chapter 13, 14, and 15, to describe IVIg Powder sales channel, distributors, customers, research findings and conclusion, appendix and data source.
❖ レポートの目次 ❖
| ★調査レポート[世界の粉末状IVIg市場2022年：市場規模予測（～2028年）] (コード：GIR22DC3840)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の粉末状IVIg市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせ |
